H-SIYRYYGL-OH

Rif. 3D-PP46914

Informazioni sul prodotto

• Nome: H-SIYRYYGL-OH
• Sinonimi: NH2-Ser-Ile-Tyr-Arg-Tyr-Tyr-Gly-Leu-OH

Descrizione

Peptide H-SIYRYYGL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SIYRYYGL-OH include the following: Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters X Lu, JS Gibbs, HD Hickman , A David - Proceedings of the , 2012 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1208696109 EXPLORING THE EMERGING ROLES OF T CELLS IN CANCER AND INFECTIOUS DISEASE W Chaisawangwong - 2022 - jscholarship.library.jhu.eduhttps://jscholarship.library.jhu.edu/bitstream/1774.2/67574/1/CHAISAWANGWONG-DISSERTATION-2022.pdf Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins TB Fessenden , LE Stopfer , F Chatterjee - for ImmunoTherapy of , 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277371/ Antigen-specific blockade of T cells in vivo using dimeric MHC peptide SM O'Herrin, JE Slansky, Q Tang - The Journal of , 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/167/5/2555/34461 A yeast display system for engineering functional peptide-MHC complexes SE Brophy, PD Holler, DM Kranz - Journal of immunological methods, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022175902004398 Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity SE Brophy, LL Jones , PD Holler, DM Kranz - Molecular immunology, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589006006924 Combinatorial peptide library methods for immunobiology research R Liu, AM Enstrom, KS Lam - Experimental hematology, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0301472X02010081 Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor R Brock, KH Wiesmuller, G Jung - Proceedings of the , 1996 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.93.23.13108 Different strategies adopted by Kb and Ld to generate T cell specificity directed against their respective bound peptides NA Bowerman, LA Colf, KC Garcia , DM Kranz - Journal of biological , 2009 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)37846-7/abstract The use of high-affinity T cell receptors to study specificity in the 2C T cell system NA Bowerman - 2009 - search.proquest.comhttps://search.proquest.com/openview/eeb7b2b1d06d6e56d878f6150fe7e477/1?pq-origsite=gscholar&cbl=18750 IL-7 receptor expression levels do not identify CD8+ memory T lymphocyte precursors following peptide immunization MH Lacombe, MP Hardy , J Rooney - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/175/7/4400/37070 Multiple Vaccinations Induce Regulatory T Cells That Reduce Therapeutic Function of Effector T Cells; Partial Depletion of CD4 Cells Restores Therapeutic Efficacy MG LaCelle, SM Jensen, BA Fox - Journal of Immunotherapy, 2006 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2006/11000/Multiple_Vaccinations_Induce_Regulatory_T_Cells.13.aspx NMR study on the interaction between MHC class I protein and its antigen peptide M Nakagawa, K Chiba-Kamoshida, K Udaka - Biochemical and , 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X00938440 Bispecific agents target endogenous murine T cells against human tumor xenografts LA Rund , BK Cho, TC Manning - journal of cancer, 1999 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0215(19990924)83:1%3C141::AID-IJC24%3E3.0.CO;2-0 Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor KW Peng, PD Holler, BA Orr , DM Kranz , SJ Russell - Gene therapy, 2004 - nature.comhttps://www.nature.com/articles/3302286 Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone. K Udaka, KH Wiesmuller, S Kienle, G Jung - Journal of immunology , 1996 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/157/2/670/29511 Adoptive Transfer of CD25-Depleted Polyclonal T Cells Into Lymphopenic Hosts Promotes Spontaneous Tumor Rejection JP Kline , I Brown, TF Gajewski - Journal of Immunotherapy, 2006 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2006/11000/Adoptive_Transfer_of_CD25_Depleted_Polyclonal_T.12.aspx Promiscuous binding of extracellular peptides to cell surface class I MHC protein HN Eisen, XH Hou , C Shen, K Wang - Proceedings of the , 2012 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1201586109 Epitope stability in single chain trimers of a major histocompatibility complex class I molecule DS Hangadoumbo - 2009 - search.proquest.comhttps://search.proquest.com/openview/c50413fb7b0eed288207aa71a6f02ee3/1?pq-origsite=gscholar&cbl=18750 Targeting tumor cells with bispecific antibodies and T cells DM Kranz , TC Manning, LA Rund , BK Cho - Journal of controlled , 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365997002393 Peptide antigen priming of naive, but not memory, CD8 T cells requires a third signal that can be provided by IL-12 CS Schmidt, MF Mescher - The Journal of Immunology, 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/168/11/5521/34221 Adjuvant effect of IL-12: conversion of peptide antigen administration from tolerizing to immunizing for CD8+ T cells in vivo CS Schmidt, MF Mescher - The Journal of Immunology, 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/163/5/2561/32848 Interleukin-12 as an adjuvant and activation signal for CD8 positive T lymphocytes in vivo CS Schmidt - 2000 - search.proquest.comhttps://search.proquest.com/openview/4ad3509a171d793e3b01263b2fbc9121/1?pq-origsite=gscholar&cbl=18750&diss=y Adoptive cell therapy using primary T lymphocytes with genetically engineered T cell receptors against melanoma and glioma C Soto - 2013 - ideals.illinois.eduhttps://www.ideals.illinois.edu/items/42424 Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice A Bai, E Higham, HN Eisen - Proceedings of the , 2008 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0805599105

• Marchio: Biosynth